Aspire Private Capital’s Celgene Corp CELG Stock Holding History

Aspire Private Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-18	Closed	-$2K	–	561
2019 Q3	$2K	Hold	18	–	–	﹤0.01%	383
2019 Q2	$2K	Hold	18	–	–	﹤0.01%	423
2019 Q1	$2K	Hold	18	–	–	﹤0.01%	473
2018 Q4	$1K	Buy	+18	New	+$1.33K	﹤0.01%	528

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Aspire Private Capital's CELG Position: Q4 2019 in Review

Aspire Private Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 18 shares — an estimated $2K sold.

Aspire Private Capital first reported a position in CELG in Q4 2018 and held it in 4 quarters. The position peaked at $2K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Aspire Private Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Aspire Private Capital sold 18 Celgene Corp shares in Q4 2019, an estimated $2K.
Aspire Private Capital first reported a position in Celgene Corp in Q4 2018 and held it in 4 quarters.
Aspire Private Capital's Celgene Corp position peaked at $2K in Q3 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Aspire Private Capital's 13F filing for Q4 2019, filed 11 Feb 2020.